Diagnosis of Neuromuscular Disorders With Specialized Electromyographic Studies
Electromyography
Neuroinflammatory Diseases+18
+ Central Nervous System Diseases
+ Central Nervous System Infections
Summary
Study start date: February 1, 2000
Actual date on which the first participant was enrolled.This is a training protocol to enable fellows in clinical neurophysiology to learn and perform technically advanced electrodiagnostic studies, such as single fiber EMG and macro EMG, on patients with neuromuscular diseases.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
INCLUSION CRITERIA: Adult patients with weakness or motor dysfunction: 8/year. Normal volunteers, adults: 2/year. EXCLUSION CRITERIA: Anticoagulation or uncorrected bleeding disorder. Children are not optimal subjects for fellows undergoing training in these techniques and will be excluded.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, United StatesOpen National Institute of Neurological Disorders and Stroke (NINDS) in Google Maps